RB 1 and p 53 at the crossroad of EMT and triple negative breast cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple pathways counteract cell death induced by RB1 loss: Implications for cancer

  2011cited by this paper
• Alterations of the retinoblastoma gene in metastatic breast cancer

  2011cited by this paper
• Critical Role of the Rb Family in Myoblast Survival and Fusion

  2011cited by this paper
• A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer.

  2011cited by this paper
• Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

  2011cited by this paper
• Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

  2010cited by this paper
• Monocarboxylate transporter 1 is up‐regulated in basal‐like breast carcinoma

  2010cited by this paper
• Glutamine addiction: a new therapeutic target in cancer.

  2010cited by this paper
• Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

  2010cited by this paper
• Molecular stratification of triple-negative breast cancers.

  2010cited by this paper
• Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency

  2010cited by this paper
• MYC as a regulator of ribosome biogenesis and protein synthesis

  2010cited by this paper
• Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

  2010cited by this paper
• Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift

  2010cited by this paper
• Targeting the RB-pathway in Cancer Therapy

  2010cited by this paper
• An atlas of combinatorial transcriptional regulation in mouse and man.

  2010cited by this paper
• Cyclins, Cdks, E2f, Skp2, and more at the first international RB Tumor Suppressor Meeting.

  2010cited by this paper
• Rb regulates fate choice and lineage commitment in vivo

  2010cited by this paper
• Differential response of triple‐negative breast cancer to a docetaxel and carboplatin‐based neoadjuvant treatment

  2010cited by this paper
• Pharmacological reactivation of mutant p53: from protein structure to the cancer patient

  2010cited by this paper
• Triple-negative breast cancer: disease entity or title of convenience?

  2010cited by this paper
• The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance.

  2010cited by this paper
• Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

  2010cited by this paper
• Mutant p53 gain-of-function in cancer.

  2010cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• PRIMA-1 reactivates mutant p53 by covalent binding to the core domain.

  2009cited by this paper
• p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

  2009cited by this paper
• Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression.

  2009cited by this paper
• Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

  2009cited by this paper
• Principles of cancer therapy: oncogene and non-oncogene addiction.

  2009cited by this paper
• Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

  2009cited by this paper
• The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy

  2009cited by this paper
• A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice.

  2009cited by this paper
• Triple-negative breast cancer--current status and future directions.

  2009cited by this paper
• Mutant p53 drives invasion by promoting integrin recycling.

  2009cited by this paper
• Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

  2009cited by this paper
• The Increasing Complexity of the Cancer Stem Cell Paradigm

  2009cited by this paper
• Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically

  2009cited by this paper
• Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.

  2008cited by this paper
• The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

  2008cited by this paper
• Cancer: Entangled pathways

  2008cited by this paper
• Cellular mechanisms of tumour suppression by the retinoblastoma gene

  2008cited by this paper
• Triple-Negative Breast Cancer: Risk Factors to Potential Targets

  2008influential reference
• Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.

  2008cited by this paper
• A Regulatory Circuit Controlling Itch-mediated p73 Degradation by Runx*

  2008cited by this paper
• Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

  2008cited by this paper
• Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

  2008cited by this paper
• Twisted epithelial–mesenchymal transition blocks senescence

  2008cited by this paper
• Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis

  2008influential reference
• Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

  2008cited by this paper
• Molecular definition of breast tumor heterogeneity.

  2007cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007influential reference
• Triple negative tumours: a critical review

  2007cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

  2007cited by this paper
• Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

  2007cited by this paper
• pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.

  2007cited by this paper
• Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

  2007cited by this paper
• Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

  2006cited by this paper
• Deconstructing the molecular portrait of basal-like breast cancer.

  2006cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

  2006cited by this paper
• A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

  2006cited by this paper
• Exploring a new twist on tumor metastasis.

  2006cited by this paper
• Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

  2006cited by this paper
• Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression

  2005cited by this paper
• pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry

  2003cited by this paper
• E2F1 as a target: promoter-driven suicide and small molecule modulators.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Breast cancer stem cells revealed

  2003cited by this paper
• The Retinoblastoma Protein Binds the Promoter of the Survival Gene bcl-2 and Regulates Its Transcription in Epithelial Cells through Transcription Factor AP-2

  2002cited by this paper
• An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal.

  2002cited by this paper
• Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

  2002cited by this paper
• Direct coupling of the cell cycle and cell death machinery by E2F

  2002cited by this paper
• Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma

  2002cited by this paper
• Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001influential reference
• Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000influential reference
• E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.

  2000cited by this paper
• Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis.

  1999cited by this paper
• BRCA1 interacts with components of the histone deacetylase complex.

  1999cited by this paper
• BRCA1-associated growth arrest is RB-dependent.

  1999cited by this paper
• pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F

  1998cited by this paper
• RB and c-Myc Activate Expression of the E-Cadherin Gene in Epithelial Cells through Interaction with Transcription Factor AP-2

  1998cited by this paper
• Lactation-induced WAP-SV40 Tag Transgene Expression in C57BL/6J Mice Leads to Mammary Carcinoma

  1998cited by this paper
• Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study.

  1997cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector

  1997cited by this paper
• Loss of Rb activates both p53‐dependent and independent cell death pathways in the developing mouse nervous system.

  1996cited by this paper
• Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

  1995cited by this paper
• Cooperative tumorigenic effects of germline mutations in Rb and p53

  1994cited by this paper
• A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

  1994cited by this paper

• The Metabolic Mechanisms of Breast Cancer Metastasis

  2021cites this paper
• Phytochemicals: Current strategies for treating breast cancer.

  2018cites this paper
• Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma

  2017cites this paper
• Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation

  2017cites this paper
• Identification of Genes Differentially Associated with Triple Negative Breast Cancers

  2017cites this paper
• RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.

  2016cites this paper
• Molecular Study of P53- and Rb-Tumor Suppressor Genes in Human Papilloma Virus-Infected Breast Cancers

  2014cites this paper
• Omics of Hereditary Breast Cancer

  2014cites this paper
• Molecular Localization of Epstein Barr Virus and Rb Tumor Suppressor Gene Expression in Tissues from Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia

  2013cites this paper
• Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

  2012cites this paper